IRIS
TETI, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.143
EU - Europa 5.895
AS - Asia 5.769
SA - Sud America 635
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 73
OC - Oceania 10
Totale 23.681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.969
SG - Singapore 2.199
CN - Cina 1.395
IE - Irlanda 1.176
RU - Federazione Russa 1.140
SE - Svezia 787
TR - Turchia 689
HK - Hong Kong 682
DE - Germania 619
IT - Italia 598
BR - Brasile 547
GB - Regno Unito 449
VN - Vietnam 402
UA - Ucraina 390
FR - Francia 313
FI - Finlandia 220
IN - India 92
BD - Bangladesh 83
CA - Canada 83
JP - Giappone 66
MX - Messico 35
NL - Olanda 34
AR - Argentina 30
BE - Belgio 30
ES - Italia 26
PL - Polonia 26
IQ - Iraq 25
ZA - Sudafrica 25
ID - Indonesia 16
LT - Lituania 16
VE - Venezuela 16
MA - Marocco 15
CZ - Repubblica Ceca 14
AT - Austria 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
EC - Ecuador 11
IL - Israele 11
CO - Colombia 10
HN - Honduras 10
SA - Arabia Saudita 10
JO - Giordania 9
PK - Pakistan 9
CL - Cile 8
CR - Costa Rica 8
JM - Giamaica 8
KR - Corea 8
AU - Australia 7
PE - Perù 7
AZ - Azerbaigian 6
EG - Egitto 6
GR - Grecia 6
GT - Guatemala 6
KE - Kenya 6
AL - Albania 5
BG - Bulgaria 5
MY - Malesia 5
PH - Filippine 5
BB - Barbados 4
KZ - Kazakistan 4
PT - Portogallo 4
RO - Romania 4
SN - Senegal 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
DZ - Algeria 3
KG - Kirghizistan 3
LB - Libano 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
RS - Serbia 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
BZ - Belize 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
IR - Iran 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BM - Bermuda 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
Totale 23.510
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.501
Singapore 1.322
Chandler 1.288
Dublin 1.173
San Jose 1.015
Dallas 751
Hong Kong 673
Ashburn 578
Santa Clara 534
Boardman 533
Council Bluffs 384
The Dalles 324
Izmir 321
San Mateo 301
Nanjing 281
Wilmington 279
New York 275
Lawrence 201
Princeton 201
Moscow 195
Lauterbourg 154
Ann Arbor 140
Beijing 139
Ho Chi Minh City 131
Los Angeles 114
Milan 113
Woodbridge 111
Hanoi 93
Nanchang 92
Seattle 88
Shenyang 87
Hefei 75
L'aquila 69
Des Moines 68
Mountain View 67
L’Aquila 61
São Paulo 60
Verona 60
Tianjin 59
Tokyo 59
Falls Church 57
Rome 56
Hebei 47
Bremen 43
Jiaxing 43
Kunming 43
Shanghai 43
Munich 39
Philadelphia 38
Phoenix 36
Dearborn 34
Kitzingen 33
Orem 33
Ningbo 31
Falkenstein 30
Toronto 29
Changsha 28
Chicago 28
Columbus 28
Guangzhou 28
Montreal 28
Frankfurt am Main 27
Chennai 26
Jinan 26
Norwalk 25
Brooklyn 24
Brussels 24
Houston 23
San Francisco 22
Helsinki 21
Warsaw 21
Zhengzhou 21
Nuremberg 20
London 19
Pune 19
Da Nang 18
Dong Ket 18
Johannesburg 16
Mexico City 16
Belo Horizonte 15
Fremont 15
Atlanta 14
Buffalo 14
Denver 14
Manchester 14
Pescara 14
Rio de Janeiro 14
Stockholm 14
Boston 13
Tappahannock 13
Turku 13
Amsterdam 12
Ankara 12
Brno 12
Lanzhou 12
Lappeenranta 12
Mumbai 12
Paris 12
Taizhou 12
Biên Hòa 11
Totale 15.405
Salva come PNG Salva come JPEG
Nome #
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 211
SMALL INTERFERING RNA (siRNA) PER LA TERAPIA DELL’OSTEOPETROSI AUTOSOMICA DOMINANTE DI TIPO 2 (ADO2) CAUSATA DA MUTAZIONE DEL GENE CLCN7 (ADO2 CLCN7-DIPENDENTE) 192
Osteoclast-poor human osteopetrosis due to mutations in RANKL 186
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 184
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 165
CALCITONIN DOWN-REGULATES IMMEDIATE CELL SIGNALS INDUCED IN HUMAN OSTEOCLAST-LIKE CELLS BY THE BONE SIALOPROTEIN-IIA FRAGMENT THROUGH A POSTINTEGRIN RECEPTOR MECHANISM 162
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 160
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 160
Osteoplastic activity of mature osteocytes evaluated by H-proline incorporation. 154
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 153
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 153
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis 151
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 151
The role of the AlphaVbeta3 integrin in the development of osteolytic bone metastases: A pharmacological target for alternative therapy? 148
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 146
Modulation of estrogen receptor levels in mouse uterus by protein kinase C isoenzymes 145
Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice 145
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 144
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 143
CALCITONIN INCREASES CYTOSOLIC-FREE CALCIUM-CONCENTRATION VIA CAPACITATIVE CALCIUM INFLUX 143
Oligodeoxynucleotide targeted to the alpha(v) gene inhibits alpha(v) integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis 142
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 142
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 141
Bone cells and the mechanisms of bone remodelling 139
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 139
Non-conventional role of haemoglobin beta in breast malignancy 138
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 137
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 137
the effect of microgravity on osteoblast metabolism 136
The "love-hate" relationship between osteoclasts and bone matrix 135
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 133
Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy 133
Ultrastructural study of human adrenal pheochromocytoma by open needle biopsy. 132
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 132
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 131
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 131
Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells 131
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 130
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 130
Bone metastasis: pathogenesis and therapeutic implications 130
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 129
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 129
Tyrosine kinase Src inhibitors: Potential therapeutic applications 129
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 129
Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2. Preclinical and clinical implications 129
Increase in cytosolic Ca2+ induced by elevation of extracellular Ca2+ in skeletal myogenic cells 128
Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells 128
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 128
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 127
OSTEOCLAST CYTOSOLIC CALCIUM, REGULATED BY VOLTAGE-GATED CALCIUM CHANNELS AND EXTRACELLULAR CALCIUM, CONTROLS PODOSOME ASSEMBLY AND BONE-RESORPTION 127
Melanoma cells stimulate osteoclastogenesis, c-src expression and osteoblast cytokines 126
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 126
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 126
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 125
PLEKHM1 is involved in osteoclastic vesicular transport and mutations in this gene cause osteopetrosis in incisors absent rat and human 125
Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood 124
Tartronates: A new generation of drugs affecting bone metabolism 124
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy 124
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 124
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 123
Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology 123
Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations 122
Signaling in osteoblasts integrates bone remodeling and energy metabolism 122
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 122
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 121
The Great Beauty of the osteoclast 121
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 121
Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma 120
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 120
An antisense oligonucleotide targeting the alpha V integrin gene inhibits adhesion and induces apoptosis in breast cancer cells 120
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro 120
A six-gene signature predicting breast cancer lung metastasis 120
Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women 120
Osteoclast isolation: New developments and methods 119
Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene 119
Imbalance of osteoclastogenesis-regulating factors in celiac disease 119
Decreased c-Src expression enhances osteoblast differentiation and bone formation 119
Osteoblasts Regulate Angiogenesis in Response to Mechanical Unloading 119
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 119
THE EFFECTS OF PARATHYROID-HORMONE OR 1,25-DIHYDROXYVITAMIN-D3 ON MONOCYTE-OSTEOCLAST FUSION 117
NEW MODEL FOR BONE-RESORPTION STUDY IN-VITRO - HUMAN OSTEOCLAST-LIKE CELLS FROM GIANT-CELL TUMORS OF BONE 117
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 116
CALCIUM RELEASE-ACTIVATED CALCIUM INFLUX IN CULTURED HUMAN MESANGIAL CELLS 116
Osteoclast genetic diseases 116
Kinome profiling of osteoblasts on hydroxyapatite opens new avenues on biomaterial cell signaling 116
ROUS-SARCOMA VIRUS-TRANSFORMED FIBROBLASTS AND CELLS OF MONOCYTIC ORIGIN DISPLAY A PECULIAR DOT-LIKE ORGANIZATION OF CYTOSKELETAL PROTEINS INVOLVED IN MICROFILAMENT MEMBRANE INTERACTIONS 116
Congenital disorders of bone and blood 116
OSTEOBLAST-OSTEOCLAST RELATIONSHIPS IN BONE-RESORPTION - OSTEOBLASTS ENHANCE OSTEOCLAST ACTIVITY IN A SERUM-FREE COCULTURE SYSTEM 115
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 115
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 115
Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis 115
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 115
Influence of calcium depletion on medullary bone of laying hens. 113
Mature osteocytes behaviour in a repletion period: the occurrence of osteoplastic activity. 113
Role of Neural (N)-Cadherin in Breast Cancer Cell Stemness and Dormancy in the Bone Microenvironment 113
A new heterozygous mutation (R714C) of the osteopetrosis gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts 112
ADHESION PROPERTIES AND INTEGRIN EXPRESSION OF CULTURED HUMAN OSTEOCLAST-LIKE CELLS 111
Immediate cell signal induced by laminin in rat Sertoli cells 111
Association of intermediate osteopetrosis with poikiloderma 111
Monocytes from circulating blood fuse in vitro with purified osteoclasts in primary culture. 110
Totale 13.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.213 0 0 343 91 62 39 33 83 103 26 77 356
2022/20233.649 285 188 69 368 349 419 5 279 1.499 14 116 58
2023/2024922 125 53 66 163 60 264 17 21 5 30 12 106
2024/20253.676 53 51 319 135 457 345 529 308 847 174 261 197
2025/20267.466 327 629 526 974 664 489 1.453 260 577 818 584 165
2026/2027526 185 269 72 0 0 0 0 0 0 0 0 0
Totale 23.681